Buy Gsk Shares -

: The total 2025 dividend was 66p (up 8.2% from 2024). Management has signaled an expected increase to 70p for 2026.

Investors are "piling into" GSK due to several key shifts in the company's fundamentals: buy gsk shares

: Despite the recent price rally, GSK still trades at a modest price-to-earnings (P/E) ratio of roughly 14–15x , which some analysts consider undervalued compared to global peers. Income Potential: Dividends : The total 2025 dividend was 66p (up 8

🎯 : GSK is scheduled to report its Q1 2026 earnings on April 29, 2026 , with analysts expecting revenue of roughly $10.24 billion . Income Potential: Dividends 🎯 : GSK is scheduled

: Ten pivotal trials are scheduled to begin this year, targeting various cancer types with Antibody-Drug Conjugates (ADCs).

GSK remains a staple for income-seeking investors, with management showing a commitment to increasing payouts: